Pharma's Almanac | Vaccine (3)

141 Articles Available

3 6

COVID-19 Vaccine

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

PR-M06-20-NI-016

Partnership

Novavax Selects AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine

PR-M06-20-NI-008

COVID-19 Vaccine

Novavax Expands Large-Scale Global Manufacturing Capacity for COVID-19 Vaccine

PR-M05-20-NI-043

COVID Vaccine

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

PR-M05-20-NI-042

COVID-19 Vaccine

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

PR-M05-20-NI-036

COVID-19 Vaccine

AstraZeneca Advances Response to COVID-19 After Receiving First Commitments for Oxford’s Potential New Vaccine

PR-M05-20-NI-033

COVID-19 Vaccine

STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection in Preclinical Studies

PR-M05-20-NI-028

COVID-19 Vaccine

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

PR-M05-20-NI-027

COVID-19 Program

USP Launches Trust Accelerated Program to Speed Development of COVID-19 Treatments and Vaccines

PR-M05-20-NI-020

Vaccine Collaboration

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

PR-M05-20-NI-001

COVID-19 Vaccine

AstraZeneca and Oxford University Announce Landmark Agreement for COVID-19 Vaccine

PR-M04-20-NI-042

FDA Approval

FDA Approves New Meningococcal Vaccination

PR-M04-20-NI-041

COVID-19 Vaccine

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

PAO-M04-20-CL-002

COVID-19 Vaccine Taskforce

UK Government Launches Vaccine Taskforce to Combat Coronavirus

PR-M04-20-NI-032

Sanofi and GSK to Join Forces in COVID-19 Vaccine Collaboration

PR-M04-20-NI-020

Moderna Highlights Opportunity of mRNA Vaccines

PR-M04-20-NI-019

Vaccine

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

PR-M04-20-NI-015

COVID-19 Vaccine

iBio Announces Advancement of COVID-19 Vaccine Program

PR-M04-20-NI-013

COVID-19

COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic

PAO-Q2-20-NI-001

Drug Delivery

COVID-19 Vaccine Delivered By Skin Patch Shows Promise

PR-M04-20-NI-012

Vaccine

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

PR-M03-20-NI-045

COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

PR-M03-20-NI-037

Vaccine

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

PR-M03-20-NI-031

Coronavirus

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus

PR-M03-20-NI-025

3 6

Vaccine (3)

141 Articles Available

Can't find what you're looking for? Try our advanced search.

COVID-19 Vaccine

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

Partnership

Novavax Selects AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine

COVID-19 Vaccine

Novavax Expands Large-Scale Global Manufacturing Capacity for COVID-19 Vaccine

COVID Vaccine

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

COVID-19 Vaccine

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

COVID-19 Vaccine

AstraZeneca Advances Response to COVID-19 After Receiving First Commitments for Oxford’s Potential New Vaccine

COVID-19 Vaccine

STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection in Preclinical Studies

COVID-19 Vaccine

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

COVID-19 Program

USP Launches Trust Accelerated Program to Speed Development of COVID-19 Treatments and Vaccines

Vaccine Collaboration

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

COVID-19 Vaccine

AstraZeneca and Oxford University Announce Landmark Agreement for COVID-19 Vaccine

FDA Approval

FDA Approves New Meningococcal Vaccination

COVID-19 Vaccine

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

COVID-19 Vaccine Taskforce

UK Government Launches Vaccine Taskforce to Combat Coronavirus

Sanofi and GSK to Join Forces in COVID-19 Vaccine Collaboration

Moderna Highlights Opportunity of mRNA Vaccines

Vaccine

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

COVID-19 Vaccine

iBio Announces Advancement of COVID-19 Vaccine Program

COVID-19

COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic

Drug Delivery

COVID-19 Vaccine Delivered By Skin Patch Shows Promise

Vaccine

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

Vaccine

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

Coronavirus

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus